48.75
price up icon1.71%   0.82
pre-market  Pre-mercato:  49.52   0.77   +1.58%
loading

Perché le azioni Sanofi Adr (SNY) sono in ribasso?

Abbiamo notato un calo di 5.69% nelle azioni di Sanofi Adr (SNY) durante la sessione di negoziazione di 2025-05-30. Sebbene ciò possa essere attribuito alla normale volatilità o a vari fattori interni ed esterni, tieni presente che stiamo monitorando attivamente la situazione e forniremo aggiornamenti tempestivi il prima possibile!
2023-10-27:

Sanofi ADS Stock (SNY) dropped by 19.13% from $53.33 to $43.13 in the trading on Friday October 27, 2023. The reason why SNY stock down today include

  • Third-quarter financial results. Sanofi's earnings were 2.55 euros per share, tumbled 11.5% year over year and were 2% below expectations. Sales slipped 4.1% to 11.96 billion euros, or about $12.33 billion. Analysts expected a stronger 12.48 billion euros.
  • Lower profit outlook: Sanofi expects its earnings per share to drop slightly in 2024, due to increased investment in research and development. The company has also abandoned its target of a 32% operating margin in 2025, in order to focus on long-term profitability.
  • Spinout of its consumer care unit: Sanofi is considering spinning off its consumer health unit into a separate company as early as the end of next year. The unit, which sells over-the-counter pain relievers and allergy medications like Doliprane and Allegra, accounts for just over 10% of Sanofi's total sales. The spinoff would likely be done through a listing on the Paris stock exchange.
$110.17
price up icon 1.75%
drug_manufacturers_general PFE
$25.14
price up icon 3.63%
$305.69
price up icon 3.32%
drug_manufacturers_general MRK
$81.61
price up icon 2.90%
drug_manufacturers_general NVO
$66.78
price up icon 2.87%
Capitalizzazione:     |  Volume (24 ore):